Indeed, the Versican protein, released by tumor cells in the extracellular space, binds TLR2, activating multiple cell types in the tumor microenvironment, including myeloid, fibroblasts, and endothelial cells, and promotes the production of many proinflammatory cytokines [44, 45]. The gene discussed is TLR2; the disease is neoplasm.